Market Tracker

12/18 5:16am ET

Advisory Board Co (NASDAQ:ABCO)

51.34
Data as of Dec 17
 +3.06 / +6.34%
Today’s Change
37.47
Today|||52-Week Range
70.14
-19.37%
Year-to-Date

Today’s Trading

Previous close48.28
Today’s open48.12
Day’s range-- - --
Volume539,502
Average volume (3 months)396,635
Market cap$1.7B
Dividend yield--
Data as of 12/17/2014

Growth & Valuation

Earnings growth (last year)+9.75%
Earnings growth (this year)+7.44%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+15.47%
P/E ratio125.2
Price/Sales4.43
Price/Book5.20

Competitors

 Today’s
change
Today’s
% change
FGENFibroGen Inc-1.69-5.81%
DYAXDyax Corp+1.06+7.88%
NKTRNektar Therapeutics+0.73+5.08%
INCRINC Research Holding...+0.21+0.89%
Data as of 12/17/2014

Financials

Next reporting dateFebruary 5, 2015
EPS forecast (this quarter)$0.25
Annual revenue (last year)$520.6M
Annual profit (last year)$24.8M
Net profit margin4.75%

Profile

Sector
Health Services
Industry
Services to the Health Industry
Chairman &
Chief Executive Officer
Robert W. Musslewhite
President &
Director
David L. Felsenthal
Corporate headquarters
Washington, District Of Columbia

Forecasts